Literature DB >> 18050146

Blood pressure load, vascular permeability and target organ damage in primary hypertension.

Valeria Falqui1, Francesca Viazzi, Giovanna Leoncini, Elena Ratto, Angelica Parodi, Novella Conti, Cinzia Tomolillo, Giacomo Deferrari, Roberto Pontremoli.   

Abstract

BACKGROUND: Target organ damage (TOD) is an often reversible subclinical condition that may precede major cardiovascular events in primary hypertensive patients. Furthermore, TOD has been shown to be a complex, multifactorial process which does not depend on blood pressure (BP) reduction alone. We therefore investigated the relationship between BP load, vascular permeability and the occurrence of TOD. PATIENTS AND METHODS: Thirty-seven never-treated, nondiabetic hypertensive patients were enrolled. Albuminuria was measured as the albumin to creatinine ratio (ACR), left ventricular mass index (LVMI) was assessed by echocardiography, systemic vascular permeability was evaluated by transcapillary escape rate of albumin (TERalb), and BP was measured by means of 24-hour ambulatory BP monitoring.
RESULTS: Patients with microalbuminuria showed higher levels of body mass index (BMI) (p<0.034), 24-hour systolic BP levels (p<0.001), left ventricular mass index (LVMI) (p=0.003) and capillary permeability to albumin (p<0.005), as compared with normoalbuminurics. Increased BP load and vascular permeability were associated with higher LVMI (p=0.012) and with an increased risk of having microalbuminuria and/or left ventricular hypertrophy (Chi square=17.4; p<0.001). Logistic regression analysis showed that the risk of having at least 1 sign of TOD was 10-fold higher in patients with TERalb above the median, and almost 5-fold higher for each 10 mm Hg increase in systolic blood pressure.
CONCLUSIONS: Abnormal vascular permeability and increased BP load are potentially modifiable risk factors that are independently associated with the development of subclinical cardiac and renal damage.

Entities:  

Mesh:

Year:  2007        PMID: 18050146

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  4 in total

1.  Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.

Authors:  Daniel Duprez; Keith Ferdinand; Das Purkayastha; Rita Samuel; Richard Wright
Journal:  Vasc Health Risk Manag       Date:  2011-11-24

2.  The "Pulse Time Index of Norm" highly correlates with the left ventricular mass index in patients with arterial hypertension.

Authors:  Igor N Posokhov; Natalya N Kulikova; Irina V Starchenkova; Elena A Grigoricheva; Vitaly V Evdokimov; Artemy V Orlov; Anatoly N Rogoza
Journal:  Vasc Health Risk Manag       Date:  2014-03-19

3.  Synaptopodin couples epithelial contractility to α-actinin-4-dependent junction maturation.

Authors:  Nivetha Kannan; Vivian W Tang
Journal:  J Cell Biol       Date:  2015-10-26       Impact factor: 10.539

4.  Effect of High-Intensity Interval Training on Body Composition, Cardiorespiratory Fitness, Blood Pressure, and Substrate Utilization During Exercise Among Prehypertensive and Hypertensive Patients With Excessive Adiposity.

Authors:  Pedro Delgado-Floody; Mikel Izquierdo; Robinson Ramírez-Vélez; Felipe Caamaño-Navarrete; Roberto Moris; Daniel Jerez-Mayorga; David C Andrade; Cristian Álvarez
Journal:  Front Physiol       Date:  2020-10-19       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.